Moderna’s SARS-CoV-2 Vaccine Phase I Data
“But one thing that you do notice as you look over the data was that day 43 was the best – there was a further evaluation at day 57, and all three groups had gone down a bit in just those two weeks.“Interesting that it was slightly weaker at day 57.If people don’t gain permanent immunity once they get covid, will this sort of drug still work?